Advertisement

Topics

Chicago Prostate Cancer Center Company Profile

07:08 EDT 23rd September 2017 | BioPortfolio


News Articles [7410 Associated News Articles listed on BioPortfolio]

Moffitt researchers identify inhibitor that overcomes drug resistance in prostate cancer

(H. Lee Moffitt Cancer Center & Research Institute) In a study published today in Cancer Cell, Moffitt Cancer Center researchers report that a newly discovered epigenetic mechanism can lead to the dev...

Geographic Factors and Health Disparities in Prostate Cancer

Socioeconomic and racial differences based on patient location may offer information on barriers to prostate cancer care. Cancer Control: Journal of the Moffitt Cancer Center

Prostate cancer symptoms aren't always obvious

(HealthDay)—Although about 1 in 7 men will be eventually be diagnosed with prostate cancer in his lifetime, the warning signs of the disease are often vague and may be confused with other conditions...

Prostate Cancer Pipeline H1 2017 Therapeutic Key Players 3-V Biosciences Inc, 4SC AG, Actinium ...

Prostate cancer is a form of cancer that affects men and starts off in the prostate gland. Prostate cancer usually occurs in older men. Symptoms Read more...

University of Colorado Cancer Center Clinical Trial Framework Tests ‘Natural’ Cures for Cancer

AURORA, Colo. (PRWEB) May 16, 2017 A University of Colorado Cancer Center clinical trial is now recruiting prostate cancer patient...

Black, white men view impacts of prostate cancer treatment differently, study finds

(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger Comprehensive Cancer Center researchers uncovered differences in the way black and white men rated prostate cancer treatment-related factors...

Prostate cancer screening reduces cancer deaths finds new analysis

There has been much debate regarding the utility of prostate cancer screening in reducing the rates of deaths due to this cancer among men. While the ERSPC (European Randomized Study of Screening for ...

New clinical trial framework tests 'natural' cures for cancer

(University of Colorado Anschutz Medical Campus) A University of Colorado Cancer Center clinical trial is now recruiting prostate cancer patients who would otherwise be on a watch-and-wait protocol to...

Drugs and Medications [630 Associated Drugs and Medications listed on BioPortfolio]

Avodart [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin CapsulesInitial U.S....

Avodart [Preferred Pharmaceuticals, Inc]

These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin CapsulesInitial U.S....

Avodart [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin CapsulesInitial U.S....

Doxazosin [Apotex Corp.]

DOXAZOSIN TABLETS, USP 1 mg, 2 mg, 4 mg and 8 mg

Doxazosin mesylate tablets 1 mg, 2 mg, 4 mg, 8 mg (doxazosin) [Genpharm Inc.]

DOXAZOSIN MESYLATE TABLETS 1 mg, 2 mg, 4 mg, 8 mg (doxazosin)

PubMed Articles [10345 Associated PubMed Articles listed on BioPortfolio]

Risk and preventive factors for prostate cancer in Japan: The Japan Public Health Center-based prospective (JPHC) study.

The incidence of prostate cancer is much lower in Asian than in Western populations. Lifestyle and dietary habits may play a major role in the etiology of this cancer. Given the possibility that risk ...

Prevention of Prostate Cancer Morbidity and Mortality: Primary Prevention and Early Detection.

More than any other cancer, prostate cancer screening with the prostate-specific antigen (PSA) tests increases the risk a man will have to face a diagnosis of prostate cancer. The best evidence from s...

c-Met, CREB1 and EGFR are involved in miR-493-5p inhibition of EMT via AKT/GSK-3β/Snail signaling in prostate cancer.

miR-493-5p downregulation has emerged as a critical player in cancer progression yet, the underlying mechanisms of miR-493-5p expression pattern and its function in prostate cancer remains to be eluci...

High Levels of Medical Mistrust Are Associated With Low Quality of Life Among Black and White Men With Prostate Cancer.

Medical mistrust is thought to affect health care-based decisions and has been linked to poor health outcomes. The effects of medical mistrust among men with prostate cancer are unknown. Thus, the goa...

The association between plasma C-peptide concentration and the risk of prostate cancer: a nested case-control study within a Japanese population-based prospective study.

The association between plasma C-peptide concentration and prostate cancer is unclear. Inconsistency of results from previous studies motivates this study. Using the Japan Public Health Center-based P...

Clinical Trials [9116 Associated Clinical Trials listed on BioPortfolio]

Molecular Mechanisms Underlying Prostate Cancer Disparities

The purpose of this study is to further elucidate the molecular mechanisms underlying prostate cancer disparities. In previous work the investigators have identified a set of differential...

Quality of Life Study for Prostate Cancer Patients

Objectives: To measure and compare health-related quality of life after treatment or management for the modalities offered as primary therapy for prostate cancer at MD Anderson Cancer Cen...

Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer

RATIONALE: Vitamin E supplements may stop or delay the development of prostate cancer in patients who are at risk of prostate cancer or who have prostate cancer. It is not yet known which ...

Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma

Dr. Frederick Millard, MD, Associate Clinical Professor at the UCSD Cancer Center, will be conducting a 12-week study in advanced prostate cancer patients. The study will be held at the U...

Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer

This study is for men who have prostate cancer that has spread outside of the prostate gland and is no longer responding to hormone removal therapy. This study is designed to determine if...

Companies [3023 Associated Companies listed on BioPortfolio]

Chicago Prostate Cancer Center

Prostate Cancer Education Council

Prostate cancer remains the second-leading cause of cancer death in American men. More than 220,000 men will be diagnosed with prostate cancer this year and it is expected that 27,000 men will die fro...

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for accelerating the world’s most promising research for discovering better t...

The Prostate Cancer Foundation

The Prostate Cancer Foundation is the world’s largest philanthropic source of support for prostate cancer research focused on discovering better treatments and a cure for pro...

Prostate Oncology Specialists, Inc.

According to the American Cancer Society, prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than two million men in the United St...

More Information about "Chicago Prostate Cancer Center" on BioPortfolio

We have published hundreds of Chicago Prostate Cancer Center news stories on BioPortfolio along with dozens of Chicago Prostate Cancer Center Clinical Trials and PubMed Articles about Chicago Prostate Cancer Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chicago Prostate Cancer Center Companies in our database. You can also find out about relevant Chicago Prostate Cancer Center Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record